Boston Scientific Corp. Issues Q2 2012 Guidance; EPS Guidance Above Analysts' Estimates; Narrows FY 2012 Revenue Guidance To A Range In Line With Analysts' Estimates; Reaffirms FY 2012 EPS Guidance

Boston Scientific Corp. announced that for second quarter of 2012, it expects sales to be in the range of $1.850-$1.950 billion. The Company expects earnings on a GAAP basis in a range of $0.06 to $0.09 per share. Adjusted earnings, excluding acquisition and restructuring related charges; and amortization expense, are estimated in a range of $0.14 to $0.17 per share (EPS). The Company estimates sales for the fiscal 2012 in a range of $7.350 billion to $7.650 billion. The Company expects earnings on a GAAP basis in a range of $0.25 to $0.38 per share. Adjusted earnings, excluding acquisition- and restructuring-related charges; and amortization expense, are estimated in a range of $0.60 to $0.70 per share. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.89 billion and EPS of $0.10 for second quarter of 2012; revenue of $7.48 billion and EPS of $0.42 for fiscal 2012.